Pathology
 |
|
30 january 2019 18:00:02 |
| Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells (Leukemia) |
|
Tweet |
| 88 viewsCategory: Pathology |
 New roles for B cell receptor associated kinases: when the B cell is not the target (Leukemia)Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance (Leukemia) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
